Tag: life sciences
-
Grant Funds Placenta Stem Cell Trial Sites for Covid-19
A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California.
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Venture Fund Plans $350M for Biotech Start-Ups
A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology.
-
Why You Should Go Back To College for Science
College isn’t all about being young, and it’s never too late to learn something new.
-
NIH Begins Covid-19 Antibody Trials
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe.
-
UCLA, Apple Partner on Depression Study
Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home technologies to detect depression.
-
New Allergy Biotech Launches, Raises $10M
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round.
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
Infographic – An Ounce of Pandemic Prevention
A recent journal article estimates the public investments needed to prevent the next damaging pandemic, against the costs imposed on the world from Covid-19.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.